Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine ± sufentanil for pediatric dental rehabilitation under general anesthesia
ChiCTR2400089116Phase 4Completed
- Sponsor
- Peking University School of Stomatology, Beijing
- Start
- Sep 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anxiety disorder and procedural sedation and analgesia (PSA) comparing Intranasal saline (placebo), Intranasal dexmedetomidine and Intranasal dexmedetomidine + sufentanil (3 arms). Primary endpoints: Scores of separation from parents and Scores of compliance with mask. Started Sep 2024; status: completed.
02
Drugs
dexmedetomidinesufentanil
03
Conditions
anxiety disorderprocedural sedation and analgesia (PSA)
Beyond the preview
Go deeper on ChiCTR2400089116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089116.